Sustained gastrointestinal colonization and systemic dissemination by Candida albicans, Candida tropicalis and Candida parapsilosis in adult mice.

The ability of nine clinical isolates of Candida species (three C. albicans, three C. tropicalis and three C. parapsilosis) to colonize and invade the gastrointestinal (GI) tract of adult male CD-1 (ICR) mice was determined. The effect of dietary tetracycline plus glucose supplementation on colonization was evaluated. Strains were intragastrically inoculated. Tetracycline and glucose altered substantially aerobic flora, especially streptococci (average fall 1.1 +/-0.3 log(10) CFU/g, p<0.01 by the Student's t test). At two weeks after oral challenge, sustained and high colonization of GI tract by Candida (mean 5,28 +/- 0.18 log(10) CFU/g, p<0.01) was achieved in all mice receiving glucose-tetracycline supplementation, excepting in animals inoculated with one of C. tropicalis isolates. Histologic sections of the stomachs revealed multiple intraepithelial micro-abscesses associated with hyphae in the region of the cardial-atrium fold. Under immunosuppression, systemic spread of C. albicans and C. tropicalis was observed in 62% and 24% of animals receiving dietary supplementation respectively. Dissemination was not noted for C. parapsilosis isolates. We have developed a simple and inexpensive murine model of sustained colonization of GI tract. This model could be useful for analyzing prophylaxis, treatment and diagnosis of systemic Candida infections and for evaluating virulence of strains.

[1]  R. Simmons,et al.  Proposed mechanisms for the translocation of intestinal bacteria. , 1988, Reviews of infectious diseases.

[2]  J. Smith,et al.  New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents , 1996, Antimicrobial agents and chemotherapy.

[3]  W. Jarvis Epidemiology of nosocomial fungal infections, with emphasis on Candida species. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  R. Greenfield,et al.  Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome , 1991, Infection and immunity.

[5]  M. Pfaller Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Wingard,et al.  Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice , 1980, Infection and immunity.

[7]  Y. Tselentis,et al.  Effects of Cefepime, Cefixime and Ceftibuten on Murine Gut Colonization by Candida albicans , 1998, Chemotherapy.

[8]  M. Phaneuf,et al.  Gastrointestinal colonization and systemic dissemination by Candida albicans and Candida tropicalis in intact and immunocompromised mice , 1992, Infection and immunity.

[9]  R. Wenzel Nosocomial candidemia: risk factors and attributable mortality. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  J. Chakir,et al.  Acquired resistance and persistence of Candida albicans following oral candidiasis in the mouse: a model of the carrier state in humans. , 1993, Oral microbiology and immunology.

[11]  E. Anaissie,et al.  The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Papadimitriou,et al.  Strain-dependent differences in host response to Candida albicans infection in mice are related to organ susceptibility and infectious load , 1996, Infection and immunity.

[13]  C. Herrera,et al.  Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy , 1982, Infection and immunity.

[14]  R. Hector,et al.  Enhanced immune responses in mice treated with penicillin-tetracycline or trimethoprim-sulfamethoxazole when colonized intragastrically with Candida albicans , 1987, Antimicrobial Agents and Chemotherapy.

[15]  A. Vázquez-Torres,et al.  Candidiasis in Interferon-γ Knockout (IFN-γ−/−) Mice , 1998 .

[16]  Y. Tselentis,et al.  Murine yeast gut flora affected by tetracycline, metronidazole and norfloxacin. , 1994, Journal of chemotherapy.

[17]  G. Ayers,et al.  Modulating effect of dietary carbohydrate supplementation on Candida albicans colonization and invasion in a neutropenic mouse model , 1993, Infection and immunity.

[18]  Y. Tselentis,et al.  Effects of broad-spectrum antibiotics on colonization of gastrointestinal tracts of mice by Candida albicans , 1994, Antimicrobial Agents and Chemotherapy.

[19]  E. Anaissie,et al.  A model of sustained gastrointestinal colonization by Candida albicans in healthy adult mice , 1990, Infection and immunity.

[20]  E Balish,et al.  Effect of oral tetracycline, the microbial flora, and the athymic state on gastrointestinal colonization and infection of BALB/c mice with Candida albicans , 1979, Infection and immunity.

[21]  M. J. Kennedy,et al.  Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism , 1985, Infection and immunity.

[22]  O. Ekenna,et al.  Factors affecting colonization and dissemination of Candida albicans from the gastrointestinal tract of mice , 1987, Infection and immunity.

[23]  G. Cole,et al.  An Animal Model for Oropharyngeal, Esophageal and Gastric Candidosis , 1990, Mycoses.